Atai Life Sciences N.V.

NASDAQ:ATAI

2.32 (USD) • At close May 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 1.555-0.0050.040.27300.0180.0870.1720.0370.0380.0240.1700.230.266019.880000
Cost of Revenue 00.16500.0820.0830.1010.0740.1950.1670.0530.0360.0190.060.02900.0190002.8130
Gross Profit 1.555-0.1480.040.191-0.083-0.0830.013-0.023-0.13-0.015-0.0120.151-0.060.2010.266-0.01919.8800-2.8130
Gross Profit Ratio 129.610.70-4.6110.149-0.134-3.514-0.395-0.50.88800.8741010000
Reseach & Development Expenses 11.32818.94212.37712.60511.44714.05513.2915.47619.28121.87619.02817.94915.4619.52813.36316.0265.5853.3523.0582.8542.144
General & Administrative Expenses 10.59711.31810.26513.39712.55519.42313.63116.55813.9715.72719.41917.22117.98225.87720.26437.3319.27371.9854.3282.8511.57
Selling & Marketing Expenses 000000000000000000000
SG&A 10.59711.31810.26513.39712.45519.42313.63116.55813.9715.72719.41917.22117.98225.87720.26437.3319.27371.9854.3282.8511.57
Other Expenses 00.00500-0.005-0.11170.6810.2040.058-1.756-0.1-0.0120-3.28-0.029-3.1891.374-2.724-13.878-1.2971.762
Operating Expenses 21.92530.2622.64226.00223.90233.47826.92132.03433.25137.60338.44735.1733.44245.40533.62753.35714.85875.3377.3865.7053.714
Operating Income -20.37-30.265-22.602-25.729-23.985-33.561-26.834-31.862-32.534-37.565-38.423-35.357-33.442-45.175-33.361-61.3194.05-87.237-7.386-5.825-3.714
Operating Income Ratio -13.16,053-565.05-94.2450-1,864.5-308.437-185.244-879.297-988.553-1,600.958-207.9820-196.413-125.41700.2040000
Total Other Income Expenses Net -5.939-8.919-3.861-31.621-1.59615.24170.6810.2040.058-1.7565.2894.5511.521-3.4046.887-5.9821.703-6.817-13.942-1.32121.615
Income Before Tax -26.309-39.184-26.463-57.35-25.681-18.3243.847-31.658-33.156-39.321-33.134-30.806-31.921-48.579-26.474-67.3015.753-91.24-21.328-7.14617.901
Income Before Tax Ratio -16.9197,836.8-661.575-210.0730-1,017.778503.989-184.058-896.108-1,034.763-1,380.583-181.2120-211.213-99.52600.2890000
Income Tax Expense 0.156-0.193-0.1780.019-0.0040.4280.2380.1850.1656.0020.1350.0510.041-4.4210.3680.0580.0060.3010.0049.355-18.254
Net Income -26.431-38.958-26.286-57.312-26.713-18.29244.244-33.042-33.321-45.323-33.269-30.857-31.962-88.877-31.158-48.4610.688-86.594-83.195-16.35716.302
Net Income Ratio -16.9977,791.6-657.15-209.9340-1,016.222508.552-192.105-900.568-1,192.711-1,386.208-181.5120-386.422-117.13500.0350000
EPS -0.15-0.24-0.16-0.36-0.17-0.120.28-0.21-0.21-0.29-0.22-0.2-0.21-0.59-0.21-0.370.005-0.57-0.55-0.110.11
EPS Diluted -0.15-0.24-0.16-0.36-0.17-0.120.28-0.21-0.21-0.29-0.21-0.2-0.21-0.59-0.21-0.370.005-0.57-0.55-0.110.11
EBITDA -25.044-38.007-25.597-56.674-24.911-17.528-26.76-30.805-32.367-37.512-33.098-30.787-31.861-38.6-33.361-53.3385.028-75.323-7.381-5.702-3.712
EBITDA Ratio -16.1057,601.4-639.925-207.5970-973.778-307.586-179.099-874.784-987.158-1,379.083-181.10-167.826-125.41700.2530000